BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2640472)

  • 1. Receptor-purified, Bolton-Hunter radioiodinated, recombinant, human epidermal growth factor: an improved radioligand for receptor studies.
    Kermode JC; Tritton TR
    J Recept Res; 1989-1990; 9(6):429-40. PubMed ID: 2640472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodination of transforming growth factor-beta (TGF-beta) in a modified Bolton-Hunter reaction system.
    Ross J; Janero DR; Hreniuk D; Wennogle LP
    J Biochem Biophys Methods; 1993 Jul; 26(4):343-50. PubMed ID: 8409206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six methods for direct radioiodination of mouse epidermal growth factor compared: effect of nonequivalence in binding behavior between labeled and unlabeled ligand.
    Kienhuis CB; Heuvel JJ; Ross HA; Swinkels LM; Foekens JA; Benraad TJ
    Clin Chem; 1991 Oct; 37(10 Pt 1):1749-55. PubMed ID: 1914179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatography of 125I-labeled mouse epidermal growth factor radioiodinated by six different methods.
    Kienhuis CB; Heuvel JJ; Ross HA; Foekens JA; Benraad TJ
    Clin Chem; 1992 May; 38(5):681-6. PubMed ID: 1582020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodination by use of the Bolton-Hunter and related reagents.
    Langone JJ
    Methods Enzymol; 1980; 70(A):221-47. PubMed ID: 7191469
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Bolton-Hunter and chloramine-T techniques for the radioiodination of prostatic acid phosphatase.
    Sturgeon CM; Beynon L; Seth J; Chisholm GD
    Ann Clin Biochem; 1983 Mar; 20 Pt 2():112-5. PubMed ID: 6682642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeling of human immune interferon with 125I-labeled Bolton-Hunter reagent.
    Anderson P
    Methods Enzymol; 1986; 119():281-3. PubMed ID: 3093805
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiolabeling of human interferon alphas with 125I-labeled Bolton-Hunter reagent.
    Zur Nedden DL; Zoon KC
    Methods Enzymol; 1986; 119():276-81. PubMed ID: 3020348
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A versatile procedure for the radioiodination of proteins and labeling reagents.
    Davison PF
    Biochim Biophys Acta; 1987 Nov; 926(2):195-202. PubMed ID: 3663710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodination of brain tubulin with Bolton-Hunter reagent.
    Carlier MF; Simon C; Pantaloni D
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1761-7. PubMed ID: 7192558
    [No Abstract]   [Full Text] [Related]  

  • 12. 125I-Labeling of platelet proteins with Bolton-Hunter reagent.
    Davies GE; Palek J
    Anal Biochem; 1981 Aug; 115(2):383-7. PubMed ID: 7197887
    [No Abstract]   [Full Text] [Related]  

  • 13. A new radioligand for the epidermal growth factor receptor: 111In labeled human epidermal growth factor derivatized with a bifunctional metal-chelating peptide.
    Rémy S; Reilly RM; Sheldon K; Gariépy J
    Bioconjug Chem; 1995; 6(6):683-90. PubMed ID: 8608180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-yield covalent attachment of epidermal growth factor to its receptor by kinetically controlled, stepwise affinity cross-linking.
    Woltjer RL; Weclas-Henderson L; Papayannopoulos IA; Staros JV
    Biochemistry; 1992 Aug; 31(32):7341-6. PubMed ID: 1324711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective labeling of alpha- or epsilon-amino groups in peptides by the Bolton-Hunter reagent.
    Gaudriault G; Vincent JP
    Peptides; 1992; 13(6):1187-92. PubMed ID: 1283630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor.
    Wu DG; Wang LH; Chi Y; Sato GH; Sato JD
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3151-5. PubMed ID: 1691502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of biologically active radioiodinated cholecystokinin for radioreceptor assay and radioimmunoassay.
    Sankaran H; Deveney CW; Goldfine ID; Williams JA
    J Biol Chem; 1979 Oct; 254(19):9349-51. PubMed ID: 226515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of epidermal growth factor receptors on plasma membranes isolated from rat gastric mucosa.
    Hori R; Nomura H; Iwakawa S; Okumura K
    Pharm Res; 1990 Jun; 7(6):665-9. PubMed ID: 2195496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of radioiodination on the binding of monoclonal antibody DF3 to breast carcinoma cells.
    Hayes DF; Noska MA; Kufe DW; Zalutsky MR
    Int J Rad Appl Instrum B; 1988; 15(3):235-41. PubMed ID: 2454899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling.
    Lax I; Burgess WH; Bellot F; Ullrich A; Schlessinger J; Givol D
    Mol Cell Biol; 1988 Apr; 8(4):1831-4. PubMed ID: 3260004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.